Respiratory Review of 2013: Pulmonary Thromboembolism
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hwang, Hun Gyu | - |
dc.contributor.author | Schulman, Sam | - |
dc.date.accessioned | 2021-08-12T00:46:43Z | - |
dc.date.available | 2021-08-12T00:46:43Z | - |
dc.date.issued | 2013-09 | - |
dc.identifier.issn | 1738-3536 | - |
dc.identifier.issn | 2005-6184 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/13403 | - |
dc.description.abstract | Pulmonary embolism (PE), which can originate as a consequence of deep vein thrombosis (DVT), is the most frequent and potentially fatal venous thromboembolic event. Despite the fact that the incidence of venous thromboembolism (VTE) in Asians is lower than that in the Western populations, a recent epidemiologic study demonstrates an increasing incidence of VTE in the Korean population. Anticoagulants, including low molecular weight heparin (LMWH) and vitamin K antagonist (VKAs), have been the main treatments for PE, however, recently new oral anticoagulants (NOACs) were introduced. We will review how well patients with PE can be managed with the existing anticoagulants and NOACs along with the time span of treatment, which still pose some challenges for clinicians. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한결핵및호흡기학회 | - |
dc.title | Respiratory Review of 2013: Pulmonary Thromboembolism | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4046/trd.2013.75.3.89 | - |
dc.identifier.scopusid | 2-s2.0-84888181690 | - |
dc.identifier.wosid | 000420490900001 | - |
dc.identifier.bibliographicCitation | Tuberculosis and Respiratory Diseases, v.75, no.3, pp 89 - 94 | - |
dc.citation.title | Tuberculosis and Respiratory Diseases | - |
dc.citation.volume | 75 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 89 | - |
dc.citation.endPage | 94 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART001805703 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Respiratory System | - |
dc.relation.journalWebOfScienceCategory | Respiratory System | - |
dc.subject.keywordPlus | DEEP-VEIN THROMBOSIS | - |
dc.subject.keywordPlus | RECURRENT VENOUS THROMBOEMBOLISM | - |
dc.subject.keywordPlus | ED AMERICAN-COLLEGE | - |
dc.subject.keywordPlus | ANTITHROMBOTIC THERAPY | - |
dc.subject.keywordPlus | COMPUTED-TOMOGRAPHY | - |
dc.subject.keywordPlus | D-DIMER | - |
dc.subject.keywordPlus | ANTICOAGULANT TREATMENT | - |
dc.subject.keywordPlus | ORAL RIVAROXABAN | - |
dc.subject.keywordPlus | EMBOLISM | - |
dc.subject.keywordPlus | PREVENTION | - |
dc.subject.keywordAuthor | Pulmonary Embolism | - |
dc.subject.keywordAuthor | Anticoagulants | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.